OmniLytics Announces Official Website

Omnilytics.com is officially posted with corporate and product information.

Salt Lake City — (March 15, 2005) OmniLytics, Inc., a biotech company that is focused on developing safe, natural solutions for infectious disease and pest control, today announced the official launch of their new Website at www.omnilytics.com.

The new site, located at www.omnilytics.com, provides official information about OmniLytics’ markets, vision, and products, and represents a major step in the company’s growth. “Our goal with this initial phase of the Website is to better communicate the extent of our work in bacteriophage research, and the markets of opportunity for our technology,” said Justin Reber, President of OmniLytics.

The site is organized into five major sections representing the markets in which OmniLytics is conducting research and developing products; Agriculture, Food and Water Safety, Industrial, Pharmaceutical, and Defense.

The Agriculture opportunity has been organized into a complete sub-site dedicated to AgriPhage™, the first-ever crop and plant bactericide product based on bacteriophage technology. Detailed product information is available on the sub-site including product overviews, application instructions, research support, customer testimonials, and frequently asked questions. The sub-site can also be reached directly using the URLs www.agriphage.com and www.agriphage.net.

OmniLytics plans to use the Website as their primary communication vehicle for publishing research work and marketing information.

To view the site online, please visit www.omnilytics.com.

About OmniLytics, Inc.

OmniLytics is a biotech company focused on developing safe, natural, effective solutions for infectious disease and pest control. OmniLytics is located in SLC, Utah. OmniLytics is pioneering research and development of bacteriophage solutions for control of microorganisms in agricultural, food & water, industrial, pharmaceutical, and defense markets. OmniLytics’ proprietary formulas and processes optimize the use of natural bacteriophage for commercial applications. For more information about OmniLytics, visit www.omnilytics.com.

Contacts:

Press or Product

Tony Swensen
OmniLytics, Inc.
801.746.3600 x304
tswensen@omnilytics.com

Business or Investments

Alan Walbeck
OmniLytics, Inc.
801.746.3600 x320
awalbeck@omnilytics.com

Contact the OmniLytics PR Department Here.